Methocarbamol
- Product NDC
- 50090-5008
- 11-digit product format
- 500905008
- Labeler code
- 50090
- Product ID
- 50090-5008_d6c42c6b-60db-423c-8f89-0ab8ccf390bb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methocarbamol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA040489
- Marketing category
- ANDA
- Marketing start
- 2019-08-15
- Substance
- METHOCARBAMOL
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040489-001 | METHOCARBAMOL | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | |
| A040489-002 | METHOCARBAMOL | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040489-001 | AA |
| A040489-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A040489-001 | METHOCARBAMOL | 500MG | TABLET / ORAL | AA | 2003-01-29 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A040489-002 | METHOCARBAMOL | 750MG | TABLET / ORAL | AA | 2003-01-29 | 4b0b4de00fa7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A040489-001 | AA | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A040489-002 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A040489-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A040489-002 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A040489-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040489-002 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A040489-001 | AA | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040489-002 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040489-001 | AA | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040489-002 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A040489-001 | AA | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A040489-002 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040489-001 | AA | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040489-002 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040489-001 | AA | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040489-002 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040489-001 | AA | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040489-002 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040489-001 | AA | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040489-002 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040489-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040489-002 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040489-001 | AA | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040489-002 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A040489-001 | AA | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A040489-002 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040489-001 | AA | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040489-002 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040489-001 | AA | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040489-002 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040489-001 | AA | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040489-002 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A040489-001 | AA | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A040489-002 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040489-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040489-002 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A040489-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A040489-002 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A040489-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A040489-002 | AA | 1 | 4b0b4de00fa7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methocarbamol
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHOCARBAMOL | 750 mg/1 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 492965be-47bc-38cf-57c4-5c5e0343abe5 | Product name | 6 | 20211028 |
| 02a01e9c-3f4e-c0ee-6542-be865127aea3 | Product name | 8 | 20190205 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5008-0 | Methocarbamol | 20 in 1 BOTTLE | TABLET | 20 | 5 | |
| 50090-5008-1 | Methocarbamol | 40 in 1 BOTTLE | TABLET | 40 | 5 | |
| 50090-5008-2 | Methocarbamol | 28 in 1 BOTTLE | TABLET | 28 | 5 | |
| 50090-5008-3 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 50090-5008-4 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 5 | |
| 50090-5008-6 | Methocarbamol | 100 in 1 BOTTLE | TABLET | 100 | 5 | |
| 50090-5008-7 | Methocarbamol | 12 in 1 BOTTLE | TABLET | 12 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5008-0 | EA - Each | 50090-5008 | eb1bbf65-7854-482a-a984-f2b6f7609ae4 | 1 | 2022-12-07 |
| 50090-5008-1 | EA - Each | 50090-5008 | f9a412ac-aaf1-40c6-99fd-19eecbace9ef | 1 | 2022-12-07 |
| 50090-5008-2 | EA - Each | 50090-5008 | 3ed133e9-08ae-4d67-b493-aee3e7fc38e4 | 1 | 2022-12-07 |
| 50090-5008-3 | EA - Each | 50090-5008 | bff20f9f-2710-4d58-b5ab-6da456ee4af6 | 1 | 2021-08-05 |
| 50090-5008-4 | EA - Each | 50090-5008 | 2668e42b-6841-43a3-b26a-a267191f638d | 1 | 2022-12-07 |
| 50090-5008-6 | EA - Each | 50090-5008 | f8dea446-4570-4e5c-a7e2-3881816b574b | 1 | 2022-12-07 |
| 50090-5008-7 | EA - Each | 50090-5008 | be173c78-6476-40ee-b001-a11737a1e127 | 1 | 2022-12-07 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5008 | METHOCARBAMOL TABLET [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 7 package rows | 20230208_d217bd1d-0b6e-4a4c-a47b-de73b94e8b13.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | NuCare Pharmaceuticals, Inc. | 1c368c79-ac60-bfa7-e063-6394a90a9ff7 | 2024-07-01 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 5a9b1104-4c9a-4c8c-9e24-719a7b3a89d7 | 2024-06-13 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | Medsource Pharmaceuticals | 127583d4-7963-bd6d-e063-6294a90ab73e | 2024-02-28 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 1637e18d-d9f9-4171-99e6-4b866d821c87 | 2024-02-07 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | Asclemed USA, Inc. | 6155b45d-3ad3-4ca4-a6ee-42885414c0e1 | 2023-10-17 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2023-09-21 | Warnings, Adverse reactions | 040489 ANDA040489 |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2023-02-06 | Warnings, Adverse reactions | 040489 ANDA040489 50090-5008 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197944 | methocarbamol 750 MG Oral Tablet | PSN | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 5 |
| 197944 | methocarbamol 750 MG Oral Tablet | SCD | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-5008-0 | 50090500800 | 20 TABLET in 1 BOTTLE (50090-5008-0) | 20 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-1 | 50090500801 | 40 TABLET in 1 BOTTLE (50090-5008-1) | 40 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-2 | 50090500802 | 28 TABLET in 1 BOTTLE (50090-5008-2) | 28 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-3 | 50090500803 | 30 TABLET in 1 BOTTLE (50090-5008-3) | 30 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-4 | 50090500804 | 60 TABLET in 1 BOTTLE (50090-5008-4) | 60 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-6 | 50090500806 | 100 TABLET in 1 BOTTLE (50090-5008-6) | 100 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |
| 50090-5008-7 | 50090500807 | 12 TABLET in 1 BOTTLE (50090-5008-7) | 12 tablet | 2020-04-15 | 0000-00-00 | No | No | Current |